Off-Label Drug Repurposing Research for Stage IV Cancer

Research into off-label drug repurposing research approaches for Stage IV Cancer. AI-powered analysis of mechanisms, evidence, and clinical status.

About Off-Label Drug Repurposing Research

AI-powered analysis of FDA-approved drugs being repurposed for novel indications — metformin, low-dose naltrexone, rapamycin, statins, and more. Leveraging existing safety profiles for new therapeutic hypotheses.

About Stage IV Cancer

Explore 14 treatment categories for advanced cancer: immunotherapy, gene therapy, antiparasitics, peptides. AI-analyzed research you can bring to your oncologist.

Standard of Care: Chemotherapy, immunotherapy (checkpoint inhibitors), targeted therapy, radiation — varies by cancer type and molecular profile.